Author

Lenaïg Maescam

Institut Paoli-Calmettes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Arnaud GuilléiD· 1 shared Bernadette de RauglaudreiD· 1 shared David Jérémie BirnbaumiD· 1 shared Émilie MamessieriD· 1 shared François BertucciiD· 1 shared Maelle PicardiD· 1 shared Nadiya BelfiliD· 1 shared Pascal FinettiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Arnaud GuilléORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multi-omic analysis of colorectal adenocarcinoma identifies a new subtype of myofibroblastic cancer-associated fibroblast expressing high level of B7-H3 and with poor prognosis value.

Maelle Picard, Arnaud Guillé, Pascal Finetti, Bernadette de Rauglaudre, Nadiya Belfil, Lenaïg Maescam, David Jérémie Birnbaum, François Bertucci, Émilie Mamessier

This study identifies a new subtype of myofibroblastic cancer-associated fibroblasts expressing high B7-H3 in colorectal cancer, which is associated with poor prognosis.

bioRxiv · Jun 30, 2025 · PreprintCancer Biology